PHARMACISTS SHOULD STILL FOLLOW LYRICA GUIDANCE, SAYS PSNC

摘要

Pharmacists should continue to follow NHS England guidance and refer generic prescriptions for pregabalin back to the prescriber if they know it has been written to treat neuropathic pain, according to the Pharmaceutical Services Negotiating Committee (PSNC). The advice comes after Pfizer lost its High Court action to protect the second medical use patent of Lyrica, its branded version of pregabalin.